ABL1 and acute lymphoblastic leukemia: Multiparameter flow cytometry, PCR based diagnostics used in ALL with BCR/ABL1 mutations, or tests based on next-generation sequencing (NGS) of clonal Ig and/or TCR loci can all be used to assess ALL MRD (42, 43).